Scotiabank raised the firm’s price target on Omega Healthcare (OHI) to $42 from $39 and keeps a Sector Perform rating on the shares. The firm is updating its price targets on stocks in the U.S. Real Estate & REITs sector under its coverage following Q2 results, the analyst tells investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- MedaSync announces strategic investment from Omega Healthcare
- Omega Healthcare Investors Reports Strong Q2 2025 Results
- Omega Healthcare Investors’ Earnings Call Highlights Robust Growth
- Omega Healthcare’s Strong Q2 Performance and Strategic Moves Justify Buy Rating
- Omega Healthcare reports Q2 adjusted FFO 77c, consensus 76c